XIDX
MBTO
Market cap11mUSD
Nov 12, Last price
192.00IDR
Name
Martina Berto Tbk PT
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Martina Berto Tbk, along with its affiliated entities, specializes in the creation and commercialization of beauty and personal care items, as well as traditional herbal remedies, catering to markets both within Indonesia and internationally. The company's operations are divided into two main areas: cosmetics and herbal products. Its extensive range of cosmetic offerings includes liquid formulations such as facial cleansers, moisturizers, toners, foundations, body colognes, and hair styling sprays; dry cosmetic products like eye shadows, blush-ons, and various loose or compact powders; and semi-solid items including lipsticks and creamy foundations. Within the herbal segment, PT Martina Berto manufactures products such as traditional facial masks, exfoliating body scrubs, and an assortment of herbal teas. Beyond direct manufacturing, the company also actively promotes and trades its beauty and herbal medicine lines. Furthermore, it serves as a contract manufacturer, producing private label dry, semi-solid, liquid, and aerosol cosmetics for other brands. Products reach consumers through a variety of distribution channels, including online platforms, major retail chains, supermarkets, wholesalers, specialized cosmetic stores, beauty salons, and spas. These offerings are marketed under established brands like Cempaka, Martina, Pesona, Biokos Martha Tilaar, Caring Colours Martha Tilaar, and Belia Martha Tilaar. Founded in 1977, PT Martina Berto Tbk maintains its headquarters in Jakarta, Indonesia, and operates as a subsidiary of PT Mathana Megahayu Inti.
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||